Assessing adherence to dermatology treatments: a review of self-report and electronic measures
Assessing adherence to dermatology treatments: a review of self-report and electronic measures
复制标题
DOI：
10.1111/j.1600-0846.2010.00431.x
复制
发表时间：
2010-05-01
影响因子：
2.2
通讯作者：
Feldman, Steven R.
中科院分区：
文献类型：
--
作者：
Greenlaw, Sheila M.;Yentzer, Brad A.;Feldman, Steven R.
背景不依从处方药物是皮肤科常见的问题，评估依从性可能很困难。电子监视器并不总是实用的，但自我报告的措施可能是不太reliable.PurposeTo审查文献的自我报告的仪器和电子监视器用于测量慢性疾病患者的药物治疗adherence.MethodsA PubMed文献检索进行使用术语“规模”，"措施“，"自我报告”，"电子"和“药物治疗依从性。相关的文章进行了审查和选择，如果他们解决自我报告或电子措施的坚持在chronic diseases.ResultsEleven自我报告工具的测量的坚持。其中四个使用电子监测器进行了验证。所有这些研究都得出了一个与实际行为相关的依从性估计值，尽管这种相关性在任何一种测量方法中都不强。在患有皮肤病和/或使用局部药物的患者中没有测试量表。确定了几个电子监测系统，包括药丸计数、药房再填充日志和药物事件监测系统（MEMS（R））。有效性更高的电子监测系统相比，自我报告measurement.ConclusionWhile几个自我报告的措施，坚持已被验证在慢性疾病人群中，其相关性在皮肤科患者尚未研究。一个皮肤病学的具体工具，用于测量的坚持将有助于改善的结果;直到这样的工具存在，研究人员和临床医生应该考虑不坚持作为一个可能的因素，皮肤病是不响应治疗。电子监测提供了最可靠的衡量遵守情况的手段，并可能提供额外的线索，以确定遵守的障碍。
BackgroundNonadherence to prescribed medications is a common problem in dermatology, and assessing adherence can be difficult. Electronic monitors are not always practical, but self-report measures may be less reliable.PurposeTo review the literature for self-report instruments and electronic monitors used to measure medication adherence in patients with chronic disease.MethodsA PubMed literature search was conducted using the terms 'scale,' 'measure,' 'self-report,' 'electronic,' and 'medication adherence.' Relevant articles were reviewed and selected if they addressed self-report or electronic measures of adherence in chronic disease.ResultsEleven self-report instruments for the measurement of adherence were identified. Four were validated using electronic monitors. All produced an estimate of adherence that correlated with actual behavior, although this correlation was not strong for any of the measures. None of the scales was tested in patients who had dermatologic disease and/or used topical medications. Several electronic monitoring systems were identified, including pill counts, pharmacy refill logs, and the Medication Event Monitoring System (MEMS (R)). Validity was higher among electronic monitoring systems compared with self-report measures.ConclusionWhile several self-report measures of adherence have been validated in chronic disease populations, their relevance in dermatology patients has not been studied. A dermatology-specific instrument for the measurement of adherence would contribute to improved outcomes; until such a tool exists, researchers and clinicians should consider nonadherence as a possible factor in skin disease that is not responsive to treatment. Electronic monitoring provides the most reliable means of measuring adherence, and may provide additional clues to identify barriers to adherence.